Norwood EyeCare Appoints Dr. Marguerite B. McDonald, M.D. Global Medical Advisor.

MELBOURNE, Australia -- Norwood Abbey Ltd. (OTC:NABYF) (ASX:NAL):

Key points:

--World-renowned surgeon, scientist and academic to advise Company on clinical and scientific strategy

--Provide clinical input on product improvements and new product development

--Provide clinical input for patient education programs

--Key participant in marketing clinical studies

Norwood Abbey Ltd. (OTC:NABYF) (ASX:NAL) subsidiary Norwood EyeCare Pty. Ltd., an innovative ophthalmic devices company, has announced the appointment of Marguerite B. McDonald M.D., F.A.C.S., to the position of global medical advisor to guide the company's product development, clinical studies and scientific growth.

Dr. McDonald, a well-known ophthalmologist and leader in corneal, cataract, refractive and laser surgery, brings over twenty years' expertise in active practice as well as research, editorial and board experience to her new position. She is the Director of the Southern Vision Institute in New Orleans, Louisiana, and is presently a Clinical Professor of Ophthalmology at Tulane University School of Medicine in New Orleans.

Dr. McDonald's extensive experience in both academia as well as in her active clinical practice ideally positions her to provide input in all facets of Norwood's EyeCare business.

In her role as Global Medical Advisor, Dr. McDonald will provide input on:

--emerging opportunities and new clinical market needs

--clinical input and guidance for product improvements and new product development

--clinical support to commercial staff on clinical issues

--patient information and education materials and brochures

Dr. McDonald will also be a key participant in an upcoming marketing clinical trial, which will commence shortly in the USA.

Dr. McDonald believes the Norwood Epi-LASIK technology is a major advancement in the area of refractive surgery. "This approach to laser vision correction will change the way that medicine is practiced. With Epi-LASIK, we can access the benefits of LASIK - quick visual recovery, minimal discomfort - as well as the safety and superb wavefront outcomes of surface ablation," stated Dr. McDonald.

Norwood Abbey is a publicly listed medical technology company, based in Melbourne, Australia. It makes a difference to people's lives by recognizing successful late stage science, patenting and protecting it, funding research to prove that it works and then finding the best commercial partner to help take the research to the patients who need it and to maximize shareholder returns. The company has two divisions: Norwood Immunology and Norwood devices. For more information, visit: www.norwoodabbey.com. For more information on Norwood EyeCare, visit www.norwoodeyecare.com.

Background information on Dr. Marguerite B. McDonald, M.D.: Dr. McDonald, is a well-known ophthalmologist and leader in corneal, cataract, refractive and laser surgery, brings over twenty years' expertise in active practice as well as research, editorial and board experience to her new position. She is the Director of the Southern Vision Institute in New Orleans, Louisiana, and is presently a Clinical Professor of Ophthalmology at Tulane University School of Medicine in New Orleans.

Dr. McDonald has received numerous scientific, teaching and research awards. She received her medical degree from Columbia University College of Physicians and Surgeons, followed by an internship at Lenox Hill Hospital and ophthalmology residency at Manhattan Eye Ear and Throat Hospital, both in New York City, and a fellowship in corneal and external diseases with Dr. Herbert E. Kaufman at the LSU Eye Center in New Orleans. Dr. McDonald was a Professor of Ophthalmology and Director of the Corneal Service at the LSU Eye Center, LSU Medical Center School of Medicine, New Orleans, as well as the Chairman of the LSUMC Promotion and Tenure Committee until September 1994.

She has become well known in the field of refractive surgery, with 344 abstracts, 64 books and book chapters, 41 interviews/panel discussions/CD ROMs/videos, and 165 peer-reviewed and 230 non-peer reviewed articles published on various refractive topics. Dr. McDonald has been the principal investigator of three National Eye Institute grants for the study of refractive surgery: radial keratotomy (at the LSU Clinical Center for the Prospective Evaluation of Radial Keratotomy (PERK) study), epikeratophakia, and excimer laser photorefractive keratectomy, as well as numerous industrial grants.

In New Orleans, Dr. McDonald headed the research team investigating the use of the excimer laser for the correction of optical error, and in 1987, performed the world's first excimer laser treatment to eliminate or reduce the need for glasses and contact lenses. Dr. McDonald treated more blind, as well as partially and fully sighted patients, in 1988; all three groups were treated for nearsightedness. In 1993, she performed the world's first excimer laser surgeries for farsightedness as well.

On October 12, 1999, Dr. McDonald performed the world's first Summit/Autonomous wavefront-based excimer laser surgeries; these cases were also the first wavefront-based laser surgeries in the U.S. This breakthrough is considered the first step on the road to the routine attainment of minimal optical aberrations and much improved night vision.

Dr. McDonald was the second physician in the United States and the third physician in the world to perform CK (Conductive Keratoplasty) for farsightedness. Dr. McDonald was the medical monitor of the U.S. clinical trials which led to FDA approval for CK.

In addition, Dr. McDonald has been honoured by selection to the editorial boards of several publications, including the Journal of Cataract and Refractive Surgery and Refractive and Corneal Surgery. In 1997, she was elected to the Executive Committee of the prestigious American Society of Cataract and Refractive Surgery (ASCRS), and was elected its first female president for the 2002-2003 term. In April 2004, Dr. McDonald completed her elected term of 8 years as Chief and Co-Chief Medical Editor of EyeWorld.

Dr. McDonald recently served as the chief medical editor for Channel 6 News, the NBC affiliate in New Orleans; she made frequent in-person appearances covering medical topics.